Quintiles rolls out contract pathology service in China

The interestingly-named Outsourcing-pharma.com reports Quintiles rolls out contract pathology service in China.

Quintiles’ new service, which is based at its College of America Pathologist (CAP) accredited central laboratory in Beijing, is intended to support the development of personalized cancer treatments.

...

While the global biopharmaceutical industry is expected to grow as a whole in the coming years, Quintiles' investment in China fits with the consensus opinion that the country will emerge as a key market in the near future.

...

Working in concert with the CRO’s other laboratories in Scotland and the US, the Beijing lab provides both immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH), as well as a wide range of bespoke biomarker assays.

This project highlights the value of digital pathology for CROs like Quintiles, as it enables them to provide better and faster service to their biopharma customers around the world.